SCHEMBL25754723

SCHEMBL25754723

CCc1cc(-c2ccc(C(C)(C)C)cc2)ccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.53
CYP2D6 P10635 2/20 0.49
PSEN1 P49768 2/20 0.49
PSEN2 P49810 2/20 0.49
APH1B Q8WW43 2/20 0.49
NCSTN Q92542 2/20 0.49
APH1A Q96BI3 2/20 0.49
PSENEN Q9NZ42 2/20 0.49
CYP3A4 P08684 1/20 0.49
SREBF1 P36956 1/20 0.44
SREBF2 Q12772 1/20 0.44
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
MAP4K4 O95819 1/20 0.40
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
KMT2A Q03164 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
AAK1 Q2M2I8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15125681 0.85 KIF11 (0.52) KIF11CYP2D6PSEN1PSEN2APH1B
SCHEMBL15125661 0.85 KIF11 (0.52) KIF11CYP2D6PSEN1PSEN2APH1B
SCHEMBL1908532 0.83 POLB (0.46) KIF11CYP2D6PSEN1PSEN2APH1B
SCHEMBL31555358 0.83 CYP1A2 (0.52) CYP2D6PSEN1PSEN2APH1BNCSTN
SCHEMBL7515433 0.80 SREBF1 (0.46) KIF11CYP2D6PSEN1PSEN2APH1B
SCHEMBL14015421 0.79 SREBF2 (0.50) CYP2D6PSEN1PSEN2APH1BNCSTN
SCHEMBL13273291 0.79 SREBF2 (0.50) CYP2D6PSEN1PSEN2APH1BNCSTN
SCHEMBL11182769 0.79 SREBF2 (0.50) CYP2D6PSEN1PSEN2APH1BNCSTN
SCHEMBL11254418 0.79 SREBF2 (0.50) CYP2D6PSEN1PSEN2APH1BNCSTN
Bromide SCHEMBL28698106 0.78 SREBF1 (0.45) KIF11CYP2D6PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023121184-A1 SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME (주)메디픽 2023-06-29 WO disclosed